paltusotine

SAN DIEGO / Austin, Texas – October 23, 2025 Crinetics Pharmaceuticals, Inc. announced new results at the 2025 North...

SAN DIEGO, Sept. 25, 2025 — The U.S. Food and Drug Administration (FDA) has approved PALSONIFY™ (paltusotine) as the...